VITROS recallZ-2266-2024 · Ortho-Clinical Diagnostics, Inc. · initiated May 21, 2024
Open, Classified
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Ortho-Clinical Diagnostics, Inc. or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
VITROS Chemistry Products FS Diluent Pack 3, Lot 01-1645 may cause results to be negatively biased when used to dilute patient samples tested with VITROS Chemistry Products CRP Slides.
FDA root cause category: Under Investigation by firm
What the company is doing
An URGENT PRODUCT CORRECTION NOTIFICATION dated 5/31/24 was sent to customers. REQUIRED ACTIONS " Discontinue using, render unusable, and discard your remaining inventory of VITROS FS Diluent Pack 3, Lot 01-1645, including packs currently loaded on your VITROS System(s). " Complete and return the enclosed Confirmation of Receipt form no later than June 10, 2024. Upon receipt of your completed Confirmation of Receipt form, QuidelOrtho will credit or replace your discarded inventory. " Save this notification with your User Documentation or post this notification by each VITROS 5,1 FS/4600/5600/XT 7600 System until the issue has been resolved. " Please forward this notification if the affected product was distributed outside of your facility. " If your laboratory has experienced the issue with this product and you have not already done so, please report the occurrence to your local Global Services Organization. DISTRIBUTOR REQUIRED ACTIONS " Discard your remaining inventory of VITROS FS Diluent Pack 3, Lot 01-1645. QuidelOrtho will credit your account. " Send the enclosed customer letter and customer Confirmation of Receipt form to all customers who were shipped VITROS FS Diluent Pack 3, Lot 01-1645, from your facility. " Complete and return the enclosed distributor Confirmation of Receipt form no later than June 10, 2024. " Please forward this notification if the affected product was distributed outside of your facility. Contact Information We apologize for the inconvenience this may cause your facility. If you have further questions, please contact Global Services Organization at 1-800-421-3311.
Recall details
- Recall number
- Z-2266-2024
- Status
- Open, Classified
- Initiated by the company
- May 21, 2024
- Posted by the FDA
- Jul 3, 2024
- Recalling firm
- Ortho-Clinical Diagnostics, Inc.
- Quantity
- 1000
- Product code
- PPM
- Distribution
- Worldwide - US Nationwide distribution in the states of FL, IL, NY, PA and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Columbia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Spain, Singapore, Sweden, The Netherlands, United Kingdom.
Product description
VITROS Chemistry Products FS Diluent Pack 3, Model/Catalog Number: 6801754. Product Description: VITROS Chemistry Products FS Diluent Pack 3 comes with 3 packs per sales unit.
Code information (models, lots, serial numbers)
Lot Code: Model No 6801754; UDI-DI 10758750007004; Lot Number 01-1645; Expiration Date: 05-Jul-2024
Devices named in this recall
1 device in the FDA device registry whose identifier appears in the recall's code information.
- VITROS 6801754Ortho-Clinical Diagnostics, Inc. · General purpose reagent2 recalls0 reports
Product lines
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 16, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page